Thu. Mar 28th, 2024

The Union Ministry of Health and Family Welfare recently reported, “The Expert Committee on vaccine administration under the chairmanship of NITI Aayog member Dr VK Paul will meet on Wednesday to consider the logistics and ethical aspects of procurement and administration of COVID-19 vaccine”.

The Committee will hold discussions with all the stakeholders including state governments and vaccine manufacturers.

The Ministry in a tweet said, “The Expert Committee on Vaccine Administration under the chairmanship of Dr V K Paul, NITI Aayog will meet on 12th August to consider logistics & ethical aspects of procurement & administration of #COVID19 vaccine”.

In another tweet, it said, “The Committee will engage with all the stakeholders including State governments and vaccine manufacturers”.

The Indian Council of Medical Research (ICMR) stated that the three India based COVID-19 vaccines are presently in different phases of clinical trials.

Top ICMR scientist (Prof) Balram Bhargava said, “At the present moment, we have three Indian vaccines that are in different phases of clinical testing. The 2 vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine”.

He added, “Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites”.

COVID-19 infection has jumped to over 22 lakh cases including 6,34,945 active cases, 15,35,744 cases of cured/discharged/migrated and 44,386 cases of death. However, the Health Ministry has highlighted that the infection is now concentrated only in 10 Indian states which accounts for more than 80 per cent of the fresh cases.

Leave a Reply

Your email address will not be published. Required fields are marked *